CARTER TODD ALFRED (Chief Scientific Officer) sold 16.2% of their position (10.50K shares) of VOYAGER THERAPEUTICS, INC. on the open market
Open‑market sale worth $85.7K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/18/2023ACC: 0001104659-23-101631
Officer· Chief Scientific Officer
Since Feb 2026
-10.50K
Net shares
Net seller
$85.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
5K acquired · 15.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+5K
Price / share
$2.85
Trade value
$14.25K
% of position
8.4%
9/15/2023
59.86K→64.86K
Common Stock
Direct
Shares
−10.50K
Price / share
$8.16
Trade value
$85.68K
% of position
16.2%
9/15/2023
64.86K→54.36K
Total
Net shares
−5.50K
Net value
-$71.43K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2023 | M · Option Exercise | +5K | $2.85 | $14.25K | 8.4% | 59.86K | 64.86K |
| Common Stock Direct | 9/15/2023 | S · Sale | −10.50K | $8.16 | $85.68K | 16.2% | 64.86K | 54.36K |
| Total | −5.50K | -$71.43K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
5K shares
Shares
−5K
Strike price
2.85
Held after
40K
Exercisable
—
9/15/2023
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock5K shares | 9/15/2023 | M · Option Exercise | −5K | 2.85 | — | 40K |